CG Oncology, Inc. (CGON) at a glance

CG Oncology, Inc. (CGON) is a mid-cap Healthcare company. It trades at $72.35, with a -15% profit margin and revenue growth of 1982.7%. It does not pay a dividend. Vestovix scores it 68/100 overall. Its strongest dimension is Safety (96/100) and its weakest is Value (40/100). It is a relatively defensive holding with below-market volatility.

Price

$72.35

Market cap

$5.25B

P/E ratio

n/a

Dividend yield

None

Beta

0.31

52-week range

$26.22 to $80.97